文献速递妇科

高剂量抗坏血酸通过促氧化功能途径在子宫浆液性癌细胞系中发挥抗肿瘤活性并增强卡铂的抑制作用

High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines.
PubMed 文献 · Gynecol Oncol · 2024-03-30

本研究在ARK1、ARK2和SPEC2子宫浆液性癌细胞系中评估高剂量抗坏血酸单独及联合卡铂的抗肿瘤作用。高剂量抗坏血酸显著抑制ARK1和SPEC2细胞增殖、诱导细胞周期阻滞、细胞应激与凋亡、增加DNA损伤并抑制侵袭;与卡铂联用较单药产生显著协同效应。作者认为抗坏血酸联合卡铂作为子宫浆液性癌辅助治疗的临床试验值得探索。

要点

  • 高剂量抗坏血酸在ARK1和SPEC2细胞中抑制增殖、诱导凋亡和DNA损伤并抑制侵袭。
  • 1 mM N-乙酰半胱氨酸可逆转抗坏血酸诱导的凋亡和增殖抑制。
  • 抗坏血酸联合卡铂较各自单药在抑制增殖和侵袭等方面产生显著协同效应。

核心结论

  • 抗坏血酸具有强效抗肿瘤活性,并通过其促氧化效应与卡铂产生协同作用。
  • 作者认为抗坏血酸联合卡铂作为子宫浆液性癌辅助治疗的临床试验值得探索。

研究设计与样本

  • 在子宫浆液性癌细胞系ARK1、ARK2和SPEC2中进行的临床前细胞实验。
  • 采用MTT法和集落形成实验评估细胞增殖,ELISA评估细胞应激、抗氧化能力、cleaved caspase 3活性和黏附,Cellometer检测细胞周期,伤口愈合实验检测侵袭,Western免疫印迹检测蛋白表达变化。

主要发现

  • 高剂量抗坏血酸在ARK1和SPEC2细胞中显著抑制细胞增殖、引起细胞周期阻滞、诱导细胞应激和凋亡、增加DNA损伤并抑制细胞侵袭。
  • 在ARK1和SPEC2两种细胞中,1 mM N-乙酰半胱氨酸处理可逆转抗坏血酸诱导的凋亡和细胞增殖抑制。
  • 在ARK1和SPEC2两种细胞中,抗坏血酸与卡铂联用较各自单药在抑制细胞增殖和侵袭、诱导细胞应激、造成DNA损伤及提高cleaved caspase 3水平方面产生显著协同效应。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Uterine serous carcinoma is a highly aggressive non-endometrioid subtype of endometrial cancer with poor survival rates overall, creating a strong need for new therapeutic strategies to improve outcomes. High-dose ascorbate (vitamin C) has been shown to inhibit cell proliferation and tumor growth in multiple preclinical models and has shown promising anti-tumor activity in combination with chemotherapy, with a favorable safety profile. We aimed to study the anti-tumor effects of ascorbate and its synergistic effect with carboplatin on uterine serous carcinoma cells. METHODS: Cell proliferation was evaluated by MTT and colony formation assays in ARK1, ARK2 and SPEC2 cells. Cellular stress, antioxidant ability, cleaved caspase 3 activity and adhesion were measured by ELISA assays. Cell cycle was detected by Cellometer. Invasion was measured using a wound healing assay. Changes in protein expression were determined by Western immunoblotting. RESULTS: High-dose ascorbate significantly inhibited cell proliferation, caused cell cycle arrest, induced cellular stress, and apoptosis, increased DNA damage, and suppressed cell invasion in ARK1 and SPEC2 cells. Treatment of both cells with 1 mM N-acetylcysteine reversed ascorbate-induced apoptosis and inhibition of cell proliferation. The combination of ascorbate and carboplatin produced significant synergistic effects in inhibiting cell proliferation and invasion, inducing cellular stress, causing DNA damage, and enhancing cleaved caspase 3 levels compared to each compound alone in both cells. CONCLUSIONS: Ascorbate has potent antitumor activity and acts synergistically with carboplatin through its pro-oxidant effects. Clinical trials of ascorbate combined with carboplatin as adjuvant treatment of uterine serous carcinoma are worth exploring.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Shen X, Wang J, Deng B, et al. High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines. Gynecol Oncol. 2024. PMID: 38555710. doi:10.1016/j.ygyno.2024.03.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。